Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Cystagon

Generic name: Cysteamine bitartrate

FDA application holder: Mylan

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Cystagon?
Cystagon is a brand name of Cysteamine bitartrate, a prescription medicine. The FDA NDC Directory lists 2 Cystagon products in 2 strengths and forms.
Who makes Cystagon?
Mylan holds the FDA application for Cystagon (NDA020392, approved August 15, 1994).
Is there a generic or store brand of Cystagon?
Other products of Cysteamine bitartrate are listed with the FDA, but none in exactly the same strength and form as a Cystagon product.
Has Cystagon been recalled?
No recall linked to Cystagon products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Cystagon is

Each Cystagon product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Cysteamine bitartrate · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
cysteamine bitartrate 150 mg
capsule (oral)
Cystagon None listed DailyMed
cysteamine bitartrate 50 mg
capsule (oral)
Cystagon None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cysteamine bitartrate →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Cystagon products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA020392MylanAugust 15, 19942

Companies that list Cystagon

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cystagon products.

Recalls

No recall linked to Cystagon products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers